Skip to main content

Advertisement

SpringerLink
Log in

Stimulant drugs

  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Stimulants are a key element in the treatment of ADHD. Carefully designed trials of stimulants have found substantial improvement in ADHD core behaviours in 65–75% of subjects with ADHD. Most standard stimulants are rapidly absorbed, with their behavioural effects appearing within 30 minutes, reaching a peak within one to three hours and disappearing within five hours. Doses at school are often necessary, in spite of the risk of peer ridicule and added adult supervision requirements. The mechanism by which stimulants act to reduce hyperactivity is not completely understood, but they improve impulsivity and activity levels. Several controlled evaluations made over periods of time greater than a year show a clear persistence of medication effects over time. A carefully crafted programme of treatment with methylphenidate is more effective in the reduction of hyperactivity symptoms than an intensive programme of behavioural and cognitive intervention. The combination of stimulants with psychosocial interventions in ADHD offers few advantages over medication alone. Unchallengeable guides to practice that would be appropriate everywhere are difficult to propose. It is imperative that clinicians prescribing stimulants should monitor the use of the drug properly, making sure that it is not being abused by the child’s family, peers or those dispensing medication at school. Polypharmacy should only be embarked on by a specialist service and the combination of methylphenidate and clonidine should be used cautiously. A part from ADHD, stimulants are useful in narcolepsy, resistant depression and partial syndromes of attention and hyperactivity. Major gaps in knowledge remain; pharmacokinetics, pharmacodynamics and pharmacogenetics of stimulant effects need further study. Details of stimulant administration regimes seem to have a major effect on the response achieved. Further research is needed, preferably in realistic practice settings, comparing different forms of combination with psychological interventions, investigating the effects in groups of children outside the core of school-aged children with typical ADHD: preschool children, adults, those with partial syndromes (such as inattentiveness) and those with co-morbid disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annual Review of Neuroscience 16: 73–93

    CAS  PubMed  Google Scholar 

  2. American Academy of Child and Adolescent Psychiatry (1997) Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 36 (Supplement 10): 85S-121S

    Google Scholar 

  3. Angrist BM, Gershon S (1972) Psychiatric sequelae of amphetamine use. In: Shader RI (ed) Psychiatric Complications of Medical Drugs. Raven, New York, pp 175–199

    Google Scholar 

  4. Anon (1984) Sustained release methylphenidate. The Medical Letter 26: 97–98

  5. Arnold LE, Abikoff HB, Cantwell D et al. (1997) National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD the (MTA): Design challenges and choices. Arch Gen Psychiatry 54: 865–870

    CAS  PubMed  Google Scholar 

  6. Barkley RA (1990) Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Guilford, New York

    Google Scholar 

  7. Bawden HN, MacDonald GW, Shea S (1997) Treatment of children with Williams syndrome with methylphenidate. Journal of Child Neurology 12: 248–252

    CAS  PubMed  Google Scholar 

  8. Berkovitch M, Pope E, Phillips J, Koren G (1995) Pemoline-associated fulminant liver failure: testing the evidence for causation. Clinical Pharmacological Therapy 57: 696–698

    CAS  Google Scholar 

  9. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV (1999) Pharmacotherapy of attention deficit-hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104: e20

    CAS  PubMed  Google Scholar 

  10. Bosse R, Furnagalli F, Jaber M, Giros B, Gainetdinov RR et al. (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neurology 19: 127–138

    CAS  Google Scholar 

  11. Bradley C (1937) The behaviour of children receiving benzedrine. American Journal of Psychiatry 94: 577–585

    Google Scholar 

  12. Caldwell JA, Caldwell JL (1997) An inflight investigation of the efficacy of dextroamphetamine for sustaining helicopter pilot performance. Aviation Space and Environmental Medicine 68 (12): 1073–80

    CAS  Google Scholar 

  13. Castellanos FX, Giedd JN, Elia J, Marsh WL et al. (1997) Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry 36: 589–596

    CAS  PubMed  Google Scholar 

  14. Diamond IR, Tannock R, Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry 38: 402–409

    CAS  PubMed  Google Scholar 

  15. Douglas VI, Barr RG, Amin K, O’Neill ME, Britton BG (1988) Dose effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry 29: 453–475

    CAS  PubMed  Google Scholar 

  16. Dunnick J, Hailey J (1995) Experimental studies on the long-term effects of methylphenidate hydrocloride. Toxicology 103: 77–84

    CAS  PubMed  Google Scholar 

  17. DuPaul G, Barkley R, McMurray M (1994) Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33: 894–903

    CAS  PubMed  Google Scholar 

  18. Elia J, Borcherding B, Rapoport J, Keysor C (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true non-responders? Psychiatry Research 36: 141–155

    CAS  PubMed  Google Scholar 

  19. Fitzpatrick P, Klorman R, Brumaghim J, Borgstedt A (1992) Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorders. Journal of the American Academy of Child and Adolescent Psychiatry 31: 226–234

    CAS  PubMed  Google Scholar 

  20. Fry JM (1998) Treatment modalities for narcolepsy. Neurology 50 (2 Supplement 1): S43–48

    Google Scholar 

  21. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S (1999) Long-term methylphenidate therapy in children with comorbid ADHD and chronic multiple tic disorder. Archives of General Psychiatry 56: 330–336

    CAS  PubMed  Google Scholar 

  22. Gainetdinov RR, Westel WC, Jones SR, Levin ED et al. (1999) role of seratonin in the paradoxical claiming effect of psychostimulants on hyperactivity. Science 283: 397–401

    CAS  PubMed  Google Scholar 

  23. Galynker I, Ieronimo C, Miner C, Rosenblum J, Vilkas N, Rosenthal RJ (1997) Methylphenidate treatment of negative symptoms in patients with dementia. Neuropsychiatry and Clinical Neuroscience 9 (2): 231–239

    CAS  Google Scholar 

  24. Gernaat HB, Haffmans PM, Knegtering H, Birkenhager TK (1995) Tranyl-cypromine in narcolepsy. Pharmacopsychiatry 28 (3): 98–100

    CAS  PubMed  Google Scholar 

  25. Gillberg C, Melander H, von Knorring A-L, Janols L-O, Thernlund G, Haeggloef B, Eideval-Wallin L, Gustaffson P, Kopp S (1997) Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: a randomized double-blind placebo-controlled trial. Archives of General Psychiatry 54: 857–864

    CAS  PubMed  Google Scholar 

  26. Gittelman-Klein R, Klein D, Katz S, Saraf K, Pollack E (1976) Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results. Archives of General Psychiatry 33: 1217–1231

    CAS  PubMed  Google Scholar 

  27. Goldman L, Genei M, Bazman R, Stonetz (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder. Journal of the American Medical Association 279: 1100–1107

    CAS  PubMed  Google Scholar 

  28. Greenhill L, Abikoff H, Conners CK et al. (1996) Medication treatment strategies in the MTA: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35: 444–454

    Google Scholar 

  29. Greenhill L, Halperin J, March J (1997) Psychostimulants. In: Tasman, A, Kay J, Lieberman J (eds) Psychiatry, Philadelphia, Saunders, pp 1659–1682

    Google Scholar 

  30. Greenhill LL, Halperin JM, Abikoff H (1999) Stimulant medication. Journal of the American Academy of Child and Adolescent Psychiatry 38: 503–512

    CAS  PubMed  Google Scholar 

  31. Grob CS, Coyle JT (1986) Suspected adverse methylphenidate-imipramine interactions in children. J Dev Behav Pediatr 7: 4265–4267

    Google Scholar 

  32. Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS (1997) Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? Journal of Pediatrics 130 (4): 670–674

    CAS  PubMed  Google Scholar 

  33. Gualtieri CT, Ondrusek MG, Finley C (1985) Attention deficit disorder in adults. Clinical Neuropharmacology 8: 343–356

    CAS  PubMed  Google Scholar 

  34. Gualtieri CT, Evans RW (1998) Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Injuries 2 (4): 273–290

    Google Scholar 

  35. Havens JF, McCaskill EO (1999) Psychostimulants in HIV-infected children and adolescents: a case series. In: Greenhill LL, Osman BB (eds) Ritalin Theory and Practice, 2nd Edition. Mary Ann Liebert, Inc. New York, pp 165–173

    Google Scholar 

  36. Hechtman L, Abikoff H (1995) Multimodel treatment plus stimulants vs stimulant treatment in ADHD children: results from a two year comparative treatment study. Paper presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, October

  37. Hickey G, Fricker P (1999) Attention deficit hyperactivity disorder, CNS stimulants and sport. Sports Medicine 27: 11–21

    CAS  PubMed  Google Scholar 

  38. Higgins ES (1999) A comparative analysis of antidepressants and stimulants for the treatment of adults with ADHD. Journal of Family Practitioners 48: 15–20

    CAS  Google Scholar 

  39. Hornyak JE, Nelson VS, Hurvitz EA (1997) The use of methylphenidate in pediatric traumatic brain injury. Pediatric Rehabilitation 1: 15–17

    CAS  PubMed  Google Scholar 

  40. Hunt RD, Minderaa RB, Cohen DJ (1986) The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate. Psychopharmacology Bulletin 22 (1): 229–236

    CAS  PubMed  Google Scholar 

  41. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK et al. (1999) Are stimulants over-prescribed? Treatment of ADHD in four US communities. Journal of the American Academy of Child and Adolescent Psychiatry 38: 797–804

    CAS  PubMed  Google Scholar 

  42. Joughin C, Zwi M (1999) FOCUS on the use of stimulants in children with attention deficit hyperactivity disorder. Primary Evidence-base Briefing No 1. College Research Unit, Royal College of Psychiatrists, London

    Google Scholar 

  43. Kavale KA, Forness SR (1983) Hyperactivity and diet treatment: a meta-analysis of the Feingold hypothesis. Journal of Learning Disabilities 16: 325–330

    Google Scholar 

  44. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S (1997) Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry 54: 1073–1080

    CAS  PubMed  Google Scholar 

  45. Kolko DJ, Bukstein OG, Barron J (1999) Methylphenidate and behavioural modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Journal of the American Academy of Child and Adolescent Psychiatry 38: 578–586

    CAS  PubMed  Google Scholar 

  46. Kosten TR, Markou A, Koob GF (1998) Depression and stimulant dependence: neurobiology and pharmacotherapy. Journal of Nervous and Mental Disorders 186 (12): 737–745

    CAS  Google Scholar 

  47. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R (1995) Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45 (11): 1956–1961

    CAS  PubMed  Google Scholar 

  48. Lichter DG, Jackson LA (1996) Predictors of clonidine response in Tourette syndrome: implications and inferences. Journal of Clinical Neurology 11 (2): 93–97

    CAS  Google Scholar 

  49. Logan BK (1996) Methamphetamine and driving impairment. Journal of Forensic Science 41 (3): 457–464

    CAS  Google Scholar 

  50. Macleod AD (1998) Methylphenidate in terminal depression. Journal of Pain Symptom Management 16 (3): 193–198

    CAS  Google Scholar 

  51. Mahalick DM, Carmel PW, Greenberg JP, Molofsky W, Brown JA, Heary RF, Marks D, Zampella E, Hodosh R, von der Schmidt E 3rd (1998) Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatric Neurosurgery 29 (3): 121–126

    CAS  PubMed  Google Scholar 

  52. Manos MJ, Short EJ, Findling RL (1999) Differential effectiveness of methylphenidate and Adderall in school-age youths with attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 38: 813–818

    CAS  PubMed  Google Scholar 

  53. Masand PS, Tesar GE (1996) Use of stimulants in the medically ill. Psychiatric Clinics of North America 19: 515–547

    CAS  PubMed  Google Scholar 

  54. Mayer G, Ewert Meier K, Hephata K (1995) Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study. Clinical Neuropharmacology 18: 306–319

    CAS  PubMed  Google Scholar 

  55. McMaster University Evidence-Based Practice Center (1999) The Treatment of Attention-Deficit Hyperactivity Disorder: An evidence Report (contract 290-97-0017) US Agency for Health Care Policy and Research. Washington DC

    Google Scholar 

  56. Mehta MA, Owen AM, Sahakain BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: RC65 (1–6)

    CAS  PubMed  Google Scholar 

  57. MTA Cooperative Group (1999) Moderators and mediators of treatment response for children with attention deficit/hyperactivity disorder. Archives of General Psychiatry 56: 1088–1096

    Google Scholar 

  58. MTA Cooperative Group (1999) Fourteen-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Archives of General Psychiatry 56: 1073–1086

    Google Scholar 

  59. Musten LM, Firestone P, Pisterman S, Bennett S, Mercer J (1997) Effects of methylphenidate on preschool children with ADHD: cognitive and behavioural functions. Journal of the American Academy of Child and Adolescent Psychiatry 15: 1047–1415

    Google Scholar 

  60. Nierenberg AA, Dougherty D, Rosenbaum JF (1998) Dopaminergic agents and stimulants as antidepressant augmentation strategies. Journal of Clinical Psychiatry 59 Supplement 5: 60–63

    CAS  PubMed  Google Scholar 

  61. Overmeyer S, Taylor E (1999) Principles for treating hyperkinetic disorder: practice approaches for the UK. J Child Psych Psychiatry 40: 1147–1157

    CAS  Google Scholar 

  62. Patrick KS, Mueller RA, Gualtieri CT, Breese GR (1987) Pharmokinetics and actions of methylphenidate. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress, 3rd ed. Raven, New York, pp 1387–1395

    Google Scholar 

  63. Pelham WE, Greenslade KE, Vodde-Hamilton MA et al. (1990) Relative efficacy of long-acting stimulants on ADHD children: a comparison of standard methylphenidate, Ritalin-SR, Dexedrine spansule, and pemoline. Pediatrics 86: 226–237

    PubMed  Google Scholar 

  64. Pelham WE, Milich R (1991) Individual differences in response to Ritalin in classwork and social behavior. In: Greenhill LL, Osman B (eds) Ritalin: Theory and Patient Management. New York, Mary Ann Liebert, pp 203–222

    Google Scholar 

  65. Pelham Jr WE, Sturges J, Hoza JA, Schmidt C, Bijlsma JJ, Milich R, Moorer S (1987) Sustained release methylphenidate and standard methylphenidate: effects on cognitive and social behaviour in children with attention deficit disorder. Pediatrics 80: 491–501

    PubMed  Google Scholar 

  66. Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ et al. (1999) A comparison of Ritalin and Adderall: efficacy and time-course in children with attention deficit/hyperactivity disorder. Pediatrics 103: e43

    CAS  PubMed  Google Scholar 

  67. Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS (1996) Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Archives of Physical Medical Rehabilitation 77: 536–540

    CAS  Google Scholar 

  68. Pliszka SR (1992) Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. Journal of the American Academy of Child and Adolescent Psychiatry 31: 197–203

    CAS  PubMed  Google Scholar 

  69. Plizka SR (1989) Effect of anxiety on cognition behaviour and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 28: 882–887

    Google Scholar 

  70. Rapoport JL, Buchsbaum MS, Weingarter H, Zahn P, Ludlow C, Mikkelsen EJ (1980) Dextroamphetamine: cognitive and behavioural effects in normal and hyperactive boys and normal men. Archives of General Psychiatry 37: 933–943

    CAS  PubMed  Google Scholar 

  71. Rapoport MD, DuPaul GJ, Kelly KL (1989) Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharmacology Bulletin 25: 285–290

    Google Scholar 

  72. Richters JE, Arnold LE, Jensen PS, Abikoff H, Conners CK et al. (1995) NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry 34: 987–1000

    CAS  PubMed  Google Scholar 

  73. Robinson LM, Sclar DA, Skaer TL, Galin RS (1999) National trends in the prevalence of attention deficit/hyperactivity disorder and prescribing of methylphenidate among school-age children: 1990–1995. Clinical Paediatrics 38: 209–217

    Google Scholar 

  74. Safer DJ, Allen RP (1989) Absence of tolerance to the behavioural effects of methylphenidate and inattentive children. Pediatrics 115: 1003–1008

    CAS  Google Scholar 

  75. Sannerud C, Feussner G (1999) Is Ritalin an abused drug? Does it meet the criteria for a Schedule II substance? In: Greenhill LL, Osman BB (eds) Ritalin theory and Practice, 2nd Edition. Mary Ann Liebert, Inc. New York, pp 27–44

    Google Scholar 

  76. Satel SL, Nelson JC (1989) Stimulants in the treatment of depression: a critical overview. Journal of Clinical Psychiatry 50: 241–249

    CAS  PubMed  Google Scholar 

  77. Schachar RJ, Tannock R, Cunningham C, Corkum PV (1997) Behavioural, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry 36: 754–763

    CAS  PubMed  Google Scholar 

  78. Schachar RJ, Ickowicz A, Tannock R (2000) Pharmacotherapy of ADHD. In: Quay H, Hogan E (eds) Handbook of Disruptive Behaviour Disorders. Plenum, New York, pp 555–565

    Google Scholar 

  79. Sokol MS, Gray NS, Goldstein A, Kaye WH (1999) Methylphenidate treatment for bulemia nervosa associated with a cluster B personality disorder. International Journal of Eating Disorders 25: 233–237

    CAS  PubMed  Google Scholar 

  80. Solanto MV, Wender EH, Bartell SS (1997) Effects of methylphenidate and behavioural contingencies on sustained attention in ADHD: a test of the reward dysfunction hypothesis. Journal of Child and Adolescent Psychopharmacology 7: 123–136

    CAS  PubMed  Google Scholar 

  81. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit hyperactivity disorder: a review and integration. Behaviour Brain Research 94: 127–152

    CAS  Google Scholar 

  82. Speech TJ, Rao SM, Osmon DC, Sperry LT (1993) A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Injuries 7: 333–338

    CAS  Google Scholar 

  83. Spencer T, Biederman J, Wilens T, Harding M, O’Donnell D, Griffin S (1996a) Pharmacotherapy of attention-deficit disorder across the life-cycle. Journal of the American Academy of Child and Adolescent Psychiatry 35: 409–432

    CAS  PubMed  Google Scholar 

  84. Spencer T, Biederman J, Harding M, O’Donnell D, Farone SV, Wilens TE (1996) Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? Journal of the American Academy of Child and Adolescent Psychiatry 35: 1460–1469

    CAS  PubMed  Google Scholar 

  85. Swanson JM, McBurnett K, Wigal T, Pfiffner LJ, Lerner MA, Williams L, Christian DL, Tamm L, Willcutt E, Crowley K, Clevenger W, Khouzam N, Woo C, Crinella FM, Fisher TD (1993) Effect of stimulant medication on children with attention deficit disorder: a “review of reviews”. Exceptional Children 60: 154–162

    Google Scholar 

  86. Swanson JM, Flockhart D, Udrea D, Cantwell D, Connor D, Williams L (1995) Clonidine in the treatment of ADHD: questions about safety and efficacy: Letter to the Editor. Journal of Child and Adolescent Psychopharmacology 5: 301–304

    Google Scholar 

  87. Swanson JM, Wigal S, Greenhill LL, Brown R et al. (1998) Analog classroom assessment of Adderall in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 37: 519–526

    CAS  PubMed  Google Scholar 

  88. Swanson JM, Conner DF, Cantwell D (1999) Combining Methylphenidate and Clonidine: III-advised. J Am Acad Child Adolesc Psychiatry 38: 617–619

    Google Scholar 

  89. Tannock R, Ickowicz, Schachar R (1995) Differential effects of MPG on working memory in ADHD children with and without comorbid anxiety: Journal of the American Academy of Child and Adolescent Psychiatry 34: 886–896

    CAS  PubMed  Google Scholar 

  90. Tannock T, Schachar, Logan GD (1995) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology, 23: 235–267

    CAS  PubMed  Google Scholar 

  91. Taylor D, Ho BT (1978) Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol, 21: 67–75

    CAS  PubMed  Google Scholar 

  92. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M (1987) Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 17: 121–143

    CAS  PubMed  Google Scholar 

  93. Taylor E, Sandberg S, Thorley G, Giles S (1991) The epidemiology of childhood hyperactivity. Maudsley Monographs 33. Oxford, Oxford University Press

    Google Scholar 

  94. Taylor E (1994) Syndromes of attention deficit and overactivit. In: Rutter M, Taylor E, Hersov L (eds) Child and Adolescent Psychiatry: Modern Approaches. Oxford, Blackwell Scientific Publications, pp 285–307

    Google Scholar 

  95. Taylor E, Sergeant J, Doefner M, Gunning B, Overmeyer S, Mobius HJ, Eisert H (1998) Guidelines for treatment of hyperkinetic disorders. European Child and Adolescent Psychiatry 7: 184–200

    CAS  PubMed  Google Scholar 

  96. Thurber S, Walker C (1983) Medication and hyperactivity; a meta-analysis. Journal of General Psychiatry 108: 79–86

    CAS  Google Scholar 

  97. US Modafinil in Narcolepsy Multicenter Study Group (1998) Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology 43: 88–97

    Google Scholar 

  98. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glorer GH, Gabrieli JD (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proceedings of the National Academy of Science USA 95: 14494–14499

    Google Scholar 

  99. van Dyck CH, McMahon TJ, Rosen MI, O’Malley SS, O’Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR (1997) Sustained-release methylpheni-date for cognitive impairment in HIV-1-infected drug abusers: a pilot study. Journal of Neuropsychiatry and Clinical Neuroscience 9: 29–36

    Google Scholar 

  100. Vance ALA, Luk ESL, Costin J, Tonge BJ, Pantelis C (1999) Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more. Australian and New Zealand Journal of Psychiatry 33: 399–406

    CAS  PubMed  Google Scholar 

  101. Volkow N, Wang G, Fowler J, Galley SJ, LOgan J, Ding YS, Hitzemann R, Dappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Americal Journal of Psychiatry 155: 1325–1331

    CAS  Google Scholar 

  102. Wagner GJ, Rabkin JG, Rabkin R (1997) Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study. Journal of Psychosomatic Research 42: 407–411

    CAS  PubMed  Google Scholar 

  103. Warneke L (1990) Psychostimulants in psychiatry. Canadian Journal of Psychiatry 35: 3–10

    CAS  Google Scholar 

  104. Whalen C, Henker B, Buhrmester D, Hinshaw S, Huber A, Laski K (1998) Does stimulant medication improve the peer status of hyperactive children? Journal of Consulting and Clinical Psychology 57: 545–549

    Google Scholar 

  105. Whitehouse D, Shah U, Palmer FB (1980) Comparison of sustained release methylphenidate in the treatment of minimal brain dysfunction. Journal of Clinical Psychiatry 41: 282–285

    CAS  PubMed  Google Scholar 

  106. Whyte J, Hart T, Schuster K, Fleming M, Polansky M, Coslett HB (1997) Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. American Journal of Physical Medical Rehabilitation 76: 440–450

    CAS  Google Scholar 

  107. Wilens TE, Biedermann J (1992) The Stimulants. Psychiatric Clinics of North America. WB Saunders, Philadelphia, Pa. pp 191–222

    Google Scholar 

  108. Wilens TE, Biederman J, Spencer TJ, Frazier J et al. (1999) Controlled trial of high doses of pemoline for adults with attention deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 19: 257–264

    CAS  PubMed  Google Scholar 

  109. Wilens TE, Spencer TJ (1999) Combining methylphenidate and clonidine: A clinically sound medication option. J Am Acad Child & Adolesc Psychiatry, 38: 614–616

    CAS  Google Scholar 

  110. Wise MS (1998) Childhood narcolepsy. Neurology 50 (2 Suppl 1): S37–42

    Google Scholar 

  111. Wroblewski B, Leary J, Phelan A, Whyte J, Manning K. (1992) Methylphenidate and seizure frequency in brain injured patients with seizure disorders. Journal of Clinical Psychiatry 53: 86–89

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child & Adolescent Psychiatry Institute of Psychiatry, Clinical Lecturer in Child & Adolescent Psychiatry, De Crespigny Park, Denmark Hill, SE5 8AF, London, UK

    Paramala Janardhanan Santosh

  2. Department of Child & Adolescent Psychiatry, Institute of Psychiatry, De Crespigny Park, Denmark Hill, SE5 8AF, London, UK

    Eric Taylor

Authors
  1. Paramala Janardhanan Santosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santosh, P.J., Taylor, E. Stimulant drugs. European Child & Adolescent Psychiatry 9 (Suppl 1), S27–S43 (2000). https://doi.org/10.1007/s007870070017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007870070017

Key words

Search

Navigation